Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Baud'Huin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Cytokine & Growth Factor Reviews|November 29, 2008
The dual role of IL-6-type cytokines on bone remodeling and bone tumorsFrédéric Blanchard, Laurence Duplomb, Marc Baud'huin, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 11, 2007
Proteoglycans: key partners in bone cell biologyFrançois Lamoureux, Marc Baud'huin, Laurence Duplomb, et al.
Cancers|February 11, 2021
Mechanisms of Resistance to Conventional Therapies for OsteosarcomaLouise Marchandet, Morgane Lallier, Céline Charrier, et al.
Photodiagnosis and Photodynamic Therapy|July 23, 2014
The influence of storage conditions on delta amino levulinic acid induced toxicity and phototoxicity in vitroAurelie Furiga, David Olivier, Marc Baud'huin, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Proteoglycans and osteolysisMarc Baud'Huin, Céline Charrier, Gwenola Bougras, et al.
The Journal of Biological Chemistry|September 18, 2009
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survivalMarc Baud'huin, Laurence Duplomb, Stéphane Téletchéa, et al.
Cells|April 2, 2020
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone SarcomasCamille Jacques, Robel Tesfaye, Melanie Lavaud, et al.
Epigenomics|December 19, 2019
BET bromodomains' functions in bone-related pathologiesCamille Jacques, Melanie Lavaud, Steven Georges, et al.
Cells|September 16, 2020
Ribosomopathies: New Therapeutic PerspectivesEmilien Orgebin, François Lamoureux, Bertrand Isidor, et al.
Endocrinology|April 12, 2008
Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3Laurence Duplomb, Marc Baud'huin, Céline Charrier, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cytokine & Growth Factor Reviews|November 29, 2008
The dual role of IL-6-type cytokines on bone remodeling and bone tumorsFrédéric Blanchard, Laurence Duplomb, Marc Baud'huin, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|July 11, 2007
Proteoglycans: key partners in bone cell biologyFrançois Lamoureux, Marc Baud'huin, Laurence Duplomb, et al.
Cancers|February 11, 2021
Mechanisms of Resistance to Conventional Therapies for OsteosarcomaLouise Marchandet, Morgane Lallier, Céline Charrier, et al.
Photodiagnosis and Photodynamic Therapy|July 23, 2014
The influence of storage conditions on delta amino levulinic acid induced toxicity and phototoxicity in vitroAurelie Furiga, David Olivier, Marc Baud'huin, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2012
Proteoglycans and osteolysisMarc Baud'Huin, Céline Charrier, Gwenola Bougras, et al.
The Journal of Biological Chemistry|September 18, 2009
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survivalMarc Baud'huin, Laurence Duplomb, Stéphane Téletchéa, et al.
Cells|April 2, 2020
Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone SarcomasCamille Jacques, Robel Tesfaye, Melanie Lavaud, et al.
Epigenomics|December 19, 2019
BET bromodomains' functions in bone-related pathologiesCamille Jacques, Melanie Lavaud, Steven Georges, et al.
Cells|September 16, 2020
Ribosomopathies: New Therapeutic PerspectivesEmilien Orgebin, François Lamoureux, Bertrand Isidor, et al.
Endocrinology|April 12, 2008
Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3Laurence Duplomb, Marc Baud'huin, Céline Charrier, et al.
Pageof 5